[1]
R. Ami, Seftika Sari, and Dwi Endarti, “COMPARISON OF ACTUAL COSTS AND INA-CBGS PACKAGE TARIFFS FOR EPOETIN ALFA COMBINED WITH FOLIC ACID VERSUS EPOETIN ALFA MONOTHERAPY IN CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING HEMODIALYSIS”, CM, vol. 11, no. 1, pp. 162–168, Mar. 2026.